Summary: The fiscal year 2025 (FY25) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation.
Distinctive Features:
· Applications are encouraged to include an exploratory aim or sub-aim to support any necessary discovery-driven research.
· Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to be derived from studies of the proposed rare cancer type(s)/subtype(s) under study.
· Research should have high potential impact on rare cancers and the patient community.
Funding Details: (New for FY25) Funding limits are now listed as total cost limits, which is the combination of both direct and indirect costs.
DOD-AMRAA
Administering federal agency